The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 19800231 |
92 |
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists. |
Schering-Plough Research Institute |
| 17300166 |
88 |
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. |
University of Montpellier |
| 21353540 |
55 |
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists. |
Msd |
| 20550119 |
96 |
Oral oxytocin antagonists. |
Drugmoldesign |
| 20719508 |
26 |
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists. |
Ligand Pharmaceuticals |
| 12502367 |
17 |
New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization. |
Université |
| 30199637 |
172 |
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism. |
Umr7200 Cnrs/Universit£ |
Search and Browse
